Global Data Exchange in Healthcare Market Forecast 2021-2028

KEY FINDINGS

The global data exchange in healthcare market is set to project a CAGR of 23.66% during the forecast period, 2021-2028. The factors propelling the market growth are the rising digitization of healthcare data, the emergence of data-driven social partnerships, and the data sharing and monetization benefits.

MARKET INSIGHTS

Data exchange in healthcare has evolved with healthcare digitization. Data is increasingly collected in large volumes by satellites, sensors, and mobile phones. The access to varied data sources, including the data outside the public domain, provides insights for many societal challenges. This leads to the emergence of new forms of partnerships between private, non-governmental, and public sectors for leveraging data for positive societal impact and the public good. These are termed 'Data Driven Social Partnerships.' Companies worldwide have included it as part of corporate social responsibility. Such aspects will aid in addressing societal problems through data sharing. However, the lack of expertise and security concerns about patient's data are projected to hinder the market growth.

REGIONAL INSIGHTS

The global data exchange in healthcare market growth assessment includes the analysis of Asia-Pacific, Europe, North America, and rest of world. North America dominated the global market in 2020. The booming healthcare sector, rising health applications like mHealth, and increasing government initiatives contribute to the market prospects of North America.

COMPETITIVE INSIGHTS

The competitive rivalry is intense, with players competing across key regions. They are vying for large market shares through expansions and new product developments. Some of the key players in the market include, Cloudticity, Burstiq LLC, Cloudtag Inc, Datavant, Cloudera, Definitive Healthcare, etc.

Our report offerings include:

• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

• 1.1. STUDY OBJECTIVES
• 1.2. SCOPE OF STUDY
• 1.3. METHODOLOGY
• 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

• 2.1. MARKET SIZE & ESTIMATES
• 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

• 3.1. KEY DRIVERS
  • 3.1.1. BENEFITS OF DATA SHARING AND MONETIZATION
  • 3.1.2. EMERGENCE OF DATA-DRIVEN SOCIAL PARTNERSHIPS
  • 3.1.3. INCREASING DIGITIZATION OF HEALTHCARE DATA
• 3.2. KEY RESTRAINTS
  • 3.2.1. NON-STANDARD AND STRICT DATA PROTECTION LAWS AND REGULATIONS
  • 3.2.2. SECURITY CONCERNS RELATED TO SENSITIVE PATIENT'S MEDICAL DATA
  • 3.2.3. LACK OF SKILLED AND EXPERT STAFF
  • 3.2.4. INADEQUATE INFRASTRUCTURE TO SUPPORT DATA SHARING

4. KEY ANALYTICS

• 4.1. IMPACT OF COVID-19 ON DATA EXCHANGE IN HEALTHCARE MARKET
• 4.2. KEY INVESTMENT INSIGHTS
• 4.3. PORTER'S FIVE FORCES ANALYSIS
  • 4.3.1. BUYERS POWER
  • 4.3.2. SUPPLIERS POWER
  • 4.3.3. SUBSTITUTION
  • 4.3.4. NEW ENTRANTS
  • 4.3.5. INDUSTRY RIVALRY
• 4.4. OPPORTUNITY MATRIX
• 4.5. VENDOR LANDSCAPE
• 4.6. KEY BUYING CRITERIA
  • 4.6.1. COST
  • 4.6.2. DATA SHARING FEATURES
  • 4.6.3. INTEROPERABILITY
• 4.7. REGULATORY FRAMEWORK

5. MARKET BY TYPE

• 5.1. BIOTECH
• 5.2. PHARMA
• 5.3. PROVIDER
• 5.4. PAYER
• 5.5. OTHER TYPES

6. GEOGRAPHICAL ANALYSIS

• 6.1. NORTH AMERICA
  • 6.1.1. KEY GROWTH ENABLERS
  • 6.1.2. KEY CHALLENGES
  • 6.1.3. KEY PLAYERS
  • 6.1.4. COUNTRY ANALYSIS
    • 6.1.4.1. UNITED STATES
    • 6.1.4.2. CANADA
• 6.2. EUROPE
  • 6.2.1. KEY GROWTH ENABLERS
  • 6.2.2. KEY CHALLENGES
  • 6.2.3. KEY PLAYERS
  • 6.2.4. COUNTRY ANALYSIS
    • 6.1.1.1. UNITED KINGDOM
    • 6.2.4.1. GERMANY
    • 6.2.4.2. FRANCE
    • 6.2.4.3. ITALY
    • 6.2.4.4. RUSSIA
    • 6.2.4.5. BELGIUM
    • 6.2.4.6. POLAND
    • 6.2.4.7. REST OF EUROPE
• 6.3. ASIA-PACIFIC
  • 6.3.1. KEY GROWTH ENABLERS
  • 6.3.2. KEY CHALLENGES
  • 6.3.3. KEY PLAYERS
  • 6.3.4. COUNTRY ANALYSIS
    • 6.3.4.1. CHINA
    • 6.3.4.2. JAPAN
    • 6.3.4.3. INDIA
    • 6.3.4.4. SOUTH KOREA
    • 6.3.4.5. INDONESIA
    • 6.3.4.6. THAILAND
    • 6.3.4.7. VIETNAM
    • 6.3.4.8. AUSTRALIA & NEW ZEALAND
    • 6.3.4.9. REST OF ASIA-PACIFIC
• 6.4. REST OF WORLD
  • 6.4.1. KEY GROWTH ENABLERS
  • 6.4.2. KEY CHALLENGES
  • 6.4.3. KEY PLAYERS
  • 6.4.4. REGIONAL ANALYSIS
    • 6.4.4.1. LATIN AMERICA
    • 6.4.4.2. MIDDLE EAST AND AFRICA

7. COMPETITIVE LANDSCAPE

• 7.1. KEY STRATEGIC DEVELOPMENTS
  • 7.1.1. MERGERS & ACQUISITIONS
  • 7.1.2. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • 7.1.3. BUSINESS EXPANSIONS/DIVESTITURES
• 7.2. COMPANY PROFILES
  • 7.2.1. AWS MARKETPLACE (AMAZON)
  • 7.2.2. BURSTIQ LLC
  • 7.2.3. CLOUDERA
  • 7.2.4. CLOUDTAG INC
  • 7.2.5. CLOUDTICITY
  • 7.2.6. DATAVANT
  • 7.2.7. DEFINITIVE HEALTHCARE
  • 7.2.8. HEALTH VERITY
  • 7.2.9. H1
  • 7.2.10. LONGENESIS
  • 7.2.11. MEDICAL CHAIN
  • 7.2.12. OPTUM
  • 7.2.13. SIEMENS HEALTHINEERS
  • 7.2.14. SNOWFLAKE
  • 7.2.15. ZENOME

LIST OF TABLES

• TABLE 1: MARKET SNAPSHOT - DATA EXCHANGE IN HEALTHCARE
• TABLE 2: REGULATORY FRAMEWORK
• TABLE 3: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 4: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 5: GLOBAL BIOTECH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 6: GLOBAL BIOTECH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 7: GLOBAL PHARMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 8: GLOBAL PHARMA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 9: GLOBAL PROVIDER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 10: GLOBAL PROVIDER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 11: GLOBAL PAYER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 12: GLOBAL PAYER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 13: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 14: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 15: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 16: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 17: NORTH AMERICA DATA EXCHANGE IN HEALTHCARE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 18: NORTH AMERICA DATA EXCHANGE IN HEALTHCARE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 19: LEADING PLAYERS OPERATING IN NORTH AMERICA DATA EXCHANGE IN HEALTHCARE MARKET
• TABLE 20: EUROPE DATA EXCHANGE IN HEALTHCARE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 21: EUROPE DATA EXCHANGE IN HEALTHCARE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 22: LEADING PLAYERS OPERATING IN EUROPE DATA EXCHANGE IN HEALTHCARE MARKET
• TABLE 23: ASIA-PACIFIC DATA EXCHANGE IN HEALTHCARE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 24: ASIA-PACIFIC DATA EXCHANGE IN HEALTHCARE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 25: LEADING PLAYERS OPERATING IN ASIA-PACIFIC DATA EXCHANGE IN HEALTHCARE MARKET
• TABLE 26: REST OF WORLD DATA EXCHANGE IN HEALTHCARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
• TABLE 27: REST OF WORLD DATA EXCHANGE IN HEALTHCARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
• TABLE 28: LEADING PLAYERS OPERATING IN REST OF WORLD DATA EXCHANGE IN HEALTHCARE MARKET
• TABLE 29: LIST OF MERGERS & ACQUISITIONS
• TABLE 30: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
• TABLE 31: LIST OF PARTNERSHIPS & AGREEMENTS
• TABLE 32: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

• FIGURE 1: KEY INVESTMENT INSIGHTS
• FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 3: OPPORTUNITY MATRIX
• FIGURE 4: VENDOR LANDSCAPE
• FIGURE 5: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020
• FIGURE 6: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY BIOTECH, 2021-2028 (IN $ MILLION)
• FIGURE 7: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY PHARMA, 2021-2028 (IN $ MILLION)
• FIGURE 8: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY PROVIDER, 2021-2028 (IN $ MILLION)
• FIGURE 9: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY PAYER, 2021-2028 (IN $ MILLION)
• FIGURE 10: GLOBAL DATA EXCHANGE IN HEALTHCARE MARKET, BY OTHER TYPES, 2021-2028 (IN $ MILLION)
• FIGURE 11: NORTH AMERICA DATA EXCHANGE IN HEALTHCARE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
• FIGURE 12: UNITED STATES DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 13: CANADA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 14: EUROPE DATA EXCHANGE IN HEALTHCARE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
• FIGURE 15: UNITED KINGDOM DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 16: GERMANY DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 17: FRANCE DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 18: ITALY DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 19: RUSSIA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 20: BELGIUM DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 21: POLAND DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 22: REST OF EUROPE DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 23: ASIA-PACIFIC DATA EXCHANGE IN HEALTHCARE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
• FIGURE 24: CHINA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 25: JAPAN DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 26: INDIA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 27: SOUTH KOREA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 28: INDONESIA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 29: THAILAND DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 30: VIETNAM DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 31: AUSTRALIA & NEW ZEALAND DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 32: REST OF ASIA-PACIFIC DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 33: REST OF WORLD DATA EXCHANGE IN HEALTHCARE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
• FIGURE 34: LATIN AMERICA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)
• FIGURE 35: MIDDLE EAST AND AFRICA DATA EXCHANGE IN HEALTHCARE MARKET, 2021-2028 (IN $ MILLION)